These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 924518)
41. Isolation of human complement component C3 from small volumes of plasma. Gresham HD; Matthews DF; Griffin FM Anal Biochem; 1986 May; 154(2):454-9. PubMed ID: 3524310 [TBL] [Abstract][Full Text] [Related]
42. An improved three-step method for the purification of the third component of human complement. Davrinche C; Rivat C; Rivat-Peran L J Immunol Methods; 1980; 35(3-4):353-9. PubMed ID: 7400589 [TBL] [Abstract][Full Text] [Related]
43. Identification of C3 beta chain as the human serum eosinophil cytotoxicity inhibitor. Minkoff MS; Wong WW; Silberstein DS J Exp Med; 1991 Nov; 174(5):1267-70. PubMed ID: 1940803 [TBL] [Abstract][Full Text] [Related]
45. Evidence that C3d is an amphiphilic protein. Application to its preparation by hydrophobic affinity chromatography. Fontaine M; Joisel F; Lebreton JP FEBS Lett; 1980 Feb; 111(1):148-51. PubMed ID: 7358154 [No Abstract] [Full Text] [Related]
46. Aseptic isolation of human complement component C3 for in vivo studies. Brinch L; Aakesson I Scand J Clin Lab Invest; 1980 Sep; 40(5):487-9. PubMed ID: 7444351 [TBL] [Abstract][Full Text] [Related]
47. Studies of pregnancy-associated murine serum proteins. Hau J; Svendsen PE; Teisner B; Svehag SE J Reprod Fertil; 1978 Nov; 54(2):239-43. PubMed ID: 722672 [TBL] [Abstract][Full Text] [Related]
48. In vitro lymphocyte reactivity during pregnancy. Loke YW; Brook SS; Allen GE Br Med J; 1976 Nov; 2(6044):1134. PubMed ID: 990813 [No Abstract] [Full Text] [Related]
49. Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Pepys MB; Hawkins PN; Kahan MC; Tennent GA; Gallimore JR; Graham D; Sabin CA; Zychlinsky A; de Diego J Circ Res; 2005 Nov; 97(11):e97-103. PubMed ID: 16254214 [TBL] [Abstract][Full Text] [Related]
50. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Hirschfield GM; Gallimore JR; Kahan MC; Hutchinson WL; Sabin CA; Benson GM; Dhillon AP; Tennent GA; Pepys MB Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8309-14. PubMed ID: 15919817 [TBL] [Abstract][Full Text] [Related]
52. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. Kopf M; Herren S; Wiles MV; Pepys MB; Kosco-Vilbois MH J Exp Med; 1998 Nov; 188(10):1895-906. PubMed ID: 9815267 [TBL] [Abstract][Full Text] [Related]
53. An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality. Bucklin SE; Silverstein R; Morrison DC Infect Immun; 1993 Aug; 61(8):3184-9. PubMed ID: 8335348 [TBL] [Abstract][Full Text] [Related]
54. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains. Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204 [TBL] [Abstract][Full Text] [Related]
55. Complement-independence of the acute-phase production of serum amyloijd P-component (SAP) in mice. Pepys MB; Rogers SL Br J Exp Pathol; 1980 Apr; 61(2):156-9. PubMed ID: 7000131 [TBL] [Abstract][Full Text] [Related]
56. Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. I. The acute phase proteins, C3 and serum amyloid P-component (SAP). Pepys MB; Baltz ML; Musallam R; Doenhoff MJ Immunology; 1980 Feb; 39(2):249-54. PubMed ID: 6966607 [TBL] [Abstract][Full Text] [Related]
57. Different allotypes of C3 degrade at different rates. Kay PH; Natsuume-Sakai S; Hayakawa J; Dawkins RL Immunogenetics; 1985; 22(6):563-9. PubMed ID: 3852778 [TBL] [Abstract][Full Text] [Related]
58. Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice. Vignali DA; Bickle QD; Taylor MG; Tennent G; Pepys MB Immunology; 1988 Jan; 63(1):55-61. PubMed ID: 3123372 [TBL] [Abstract][Full Text] [Related]
59. Isolation and characterization of the third component of rat complement. Daha MR; Stuffers-Heiman M; Kijlstra A; van Es LA Immunology; 1979 Jan; 36(1):63-70. PubMed ID: 422228 [TBL] [Abstract][Full Text] [Related]